Variables | Non-standardized coefficient | Standardized coefficient | Assessment parameters | ||
---|---|---|---|---|---|
B | β | T | p | VIF | |
Drug | |||||
Aflibercept | 0 | – | – | – | – |
Bevacizumab | 0.852 | 0.318 | 3.600 | < 0.001 | 1.6 |
Ranibizumab | 1.309 | 0.493 | 5.608 | < 0.001 | 1.6 |
Ziv-aflibercept | 0.853 | 0.321 | 3.676 | < 0.001 | 1.6 |
Baseline CRT | 0.002 | 0.131 | 1.718 | 0.088 | 1.2 |
HRF | |||||
No | 0 | – | – | – | – |
Yes | 0.781 | 0.253 | 3.515 | 0.001 | 1.1 |
SHRM | |||||
No | 0 | – | – | – | – |
Yes | 0.520 | 0.212 | 2.734 | 0.007 | 1.2 |